AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $203,700,000 | +53.3% | 15,000,000 | -14.4% | 2.54% | +29.7% |
| Q1 2020 | $132,862,000 | +7.4% | 17,527,968 | -10.4% | 1.96% | +43.6% |
| Q4 2019 | $123,692,000 | +28.9% | 19,571,453 | -20.0% | 1.37% | +25.8% |
| Q3 2019 | $95,928,000 | -19.0% | 24,471,453 | 0.0% | 1.09% | +1.3% |
| Q2 2019 | $118,442,000 | -40.9% | 24,471,453 | 0.0% | 1.07% | -36.3% |
| Q1 2019 | $200,421,000 | +48.1% | 24,471,453 | 0.0% | 1.68% | +43.4% |
| Q4 2018 | $135,327,000 | – | 24,471,453 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |